Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, 197758 St.-Petersburg, Russia.
Department of Medical Genetics, St.-Petersburg Pediatric Medical University, 194100 St.-Petersburg, Russia.
Int J Mol Sci. 2022 Apr 21;23(9):4586. doi: 10.3390/ijms23094586.
DNA from formalin-fixed paraffin-embedded (FFPE) tissues, which are frequently utilized in cancer research, is significantly affected by chemical degradation. It was suggested that approaches that are based on duplex sequencing can significantly improve the accuracy of mutation detection in FFPE-derived DNA. However, the original duplex sequencing method cannot be utilized for the analysis of formalin-fixed paraffin-embedded (FFPE) tissues, as FFPE DNA contains an excessive number of damaged bases, and these lesions are converted to false double-strand nucleotide substitutions during polymerase-driven DNA end repair process. To resolve this drawback, we replaced DNA polymerase by a single strand-specific nuclease P1. Nuclease P1 was shown to efficiently remove RNA from DNA preparations, to fragment the FFPE-derived DNA and to remove 5'/3'-overhangs. To assess the performance of duplex sequencing-based methods in FFPE-derived DNA, we constructed the Bottleneck Sequencing System (BotSeqS) libraries from five colorectal carcinomas (CRCs) using either DNA polymerase or nuclease P1. As expected, the number of identified mutations was approximately an order of magnitude higher in libraries prepared with DNA polymerase vs. nuclease P1 (626 ± 167/Mb vs. 75 ± 37/Mb, paired -test -value 0.003). Furthermore, the use of nuclease P1 but not polymerase-driven DNA end repair allowed a reliable discrimination between CRC tumors with and without hypermutator phenotypes. The utility of newly developed modification was validated in the collection of 17 CRCs and 5 adjacent normal tissues. Nuclease P1 can be recommended for the use in duplex sequencing library preparation from FFPE-derived DNA.
来自福尔马林固定石蜡包埋(FFPE)组织的 DNA 受到化学降解的严重影响,FFPE 组织经常用于癌症研究。基于双测序的方法被建议可以显著提高 FFPE 衍生 DNA 中突变检测的准确性。然而,原始的双测序方法不能用于分析福尔马林固定石蜡包埋(FFPE)组织,因为 FFPE DNA 中含有过多的受损碱基,这些损伤在聚合酶驱动的 DNA 末端修复过程中会转化为假双链核苷酸取代。为了解决这个缺点,我们用单链特异性核酸酶 P1 代替 DNA 聚合酶。核酸酶 P1 被证明可以有效地从 DNA 制剂中去除 RNA,片段化 FFPE 衍生的 DNA,并去除 5'/3'-突出端。为了评估基于双测序方法在 FFPE 衍生 DNA 中的性能,我们使用 DNA 聚合酶或核酸酶 P1 从五个结直肠癌(CRC)构建了瓶颈测序系统(BotSeqS)文库。正如预期的那样,用 DNA 聚合酶制备的文库中鉴定的突变数量大约比用核酸酶 P1 高一个数量级(626±167/Mb 与 75±37/Mb,配对检验值为 0.003)。此外,使用核酸酶 P1 而不是聚合酶驱动的 DNA 末端修复,可以可靠地区分具有和不具有高突变表型的 CRC 肿瘤。新开发的修饰方法在 17 个 CRC 和 5 个相邻正常组织的收集物中得到了验证。核酸酶 P1 可以推荐用于从 FFPE 衍生的 DNA 中制备双测序文库。